Faes Farma SA (FAE) - Total Liabilities
Based on the latest financial reports, Faes Farma SA (FAE) has total liabilities worth €594.19 Million EUR (≈ $694.67 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Faes Farma SA - Total Liabilities Trend (2000–2025)
This chart illustrates how Faes Farma SA's total liabilities have evolved over time, based on quarterly financial data. See FAE working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Faes Farma SA Competitors by Total Liabilities
The table below lists competitors of Faes Farma SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai QiFan Cable Co Ltd
SHG:605222
|
China | CN¥10.05 Billion |
|
Kelington Group Bhd
KLSE:0151
|
Malaysia | RM645.95 Million |
|
Proeduca Altus S.A.
MC:PRO
|
Spain | €275.33 Million |
|
Globant SA
F:2G2
|
Germany | €1.16 Billion |
|
Marqeta Inc
NASDAQ:MQ
|
USA | $734.43 Million |
|
Tangshan Jidong Cement Co Ltd
SHE:000401
|
China | CN¥28.94 Billion |
|
China Resources Chemical Innovative Materials Co. Ltd.
SHE:301090
|
China | CN¥2.13 Billion |
|
Kolon Industries Inc
KO:120110
|
Korea | ₩3.71 Trillion |
Liability Composition Analysis (2000–2025)
This chart breaks down Faes Farma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see FAE market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Faes Farma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Faes Farma SA (2000–2025)
The table below shows the annual total liabilities of Faes Farma SA from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €594.19 Million ≈ $694.67 Million |
+369.85% |
| 2024-12-31 | €126.46 Million ≈ $147.85 Million |
+12.23% |
| 2023-12-31 | €112.68 Million ≈ $131.73 Million |
-8.68% |
| 2022-12-31 | €123.39 Million ≈ $144.26 Million |
+18.99% |
| 2021-12-31 | €103.70 Million ≈ $121.23 Million |
+13.61% |
| 2020-12-31 | €91.27 Million ≈ $106.71 Million |
+14.06% |
| 2019-12-31 | €80.02 Million ≈ $93.55 Million |
-33.68% |
| 2018-12-31 | €120.65 Million ≈ $141.05 Million |
+10.22% |
| 2017-12-31 | €109.47 Million ≈ $127.98 Million |
+136.25% |
| 2016-12-31 | €46.34 Million ≈ $54.17 Million |
+27.50% |
| 2015-12-31 | €36.34 Million ≈ $42.49 Million |
-5.87% |
| 2014-12-31 | €38.61 Million ≈ $45.14 Million |
-55.80% |
| 2013-12-31 | €87.35 Million ≈ $102.12 Million |
-14.39% |
| 2012-12-31 | €102.03 Million ≈ $119.28 Million |
-17.39% |
| 2011-12-31 | €123.51 Million ≈ $144.39 Million |
-6.14% |
| 2010-12-31 | €131.59 Million ≈ $153.84 Million |
+16.41% |
| 2009-12-31 | €113.04 Million ≈ $132.15 Million |
-4.45% |
| 2008-12-31 | €118.31 Million ≈ $138.31 Million |
-2.53% |
| 2007-12-31 | €121.38 Million ≈ $141.90 Million |
+31.10% |
| 2006-12-31 | €92.58 Million ≈ $108.24 Million |
+9.67% |
| 2005-12-31 | €84.42 Million ≈ $98.69 Million |
+22.55% |
| 2004-12-31 | €68.89 Million ≈ $80.53 Million |
-14.05% |
| 2003-12-31 | €80.15 Million ≈ $93.70 Million |
+17.00% |
| 2002-12-31 | €68.50 Million ≈ $80.08 Million |
-99.08% |
| 2001-12-31 | €7.47 Billion ≈ $8.74 Billion |
+8.06% |
| 2000-12-31 | €6.91 Billion ≈ $8.08 Billion |
-- |
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants servic… Read more